TTrialPathMatch Me to Trials
← Back to trials
RecruitingDiabetes Mellitus, Type 2Genetics

Phenotyping Genetic Risk for Type 2 Diabetes

Eligible age

10–70 yrs

Accepts

All genders

Locations

1 state

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This study tests the hypothesis that non-diabetic individuals with a high genetic risk score for type 2 diabetes have impaired glucose tolerance and insulin resistance compared to those with a low genetic risk score for type 2 diabetes.

Sponsor: University of Pennsylvania

You may qualify if…

  • Age 10-70 years
  • Prior participant of the UPenn Biobank or Center for Applied Genomics Biobank and agreed to be recontacted for future research.
  • Adults with BMI 25kg/m2 or higher, children and adolescents with BMI 85th percentile or higher

You may not qualify if…

  • prior diagnosis of type 1, type 2, or secondary diabetes
  • use of medications that would impact glucose and insulin response such as steroids, metformin or other anti-diabetic medication
  • acute illness that may impact insulin and glucose dynamics
  • pregnancy
  • hypothalamic obesity or related genetic disorder of metabolism
  • recent systemic chemotherapy use
  • gastrointestinal impairment or surgery that may impact absorption
  • anemia

Where it's recruiting

Pennsylvania

Philadelphia

Source: ClinicalTrials.gov · NCT04024631 · last updated 2025-09-10

Phenotyping Genetic Risk for Type 2 Diabetes · TrialPath